Use access key #2 to skip to page content.
$3.15 -0.52 (-14.17%)
10/10/2008 4:00 PM

BioSante Pharmaceuticals, Inc. (BPAX)

CAPS Rating:
**

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

View All Commentary (BPAX)

Recs

1

Avatar tibber61 (88.24) Submitted: 3/28/07 9:28 PM : Outperform Start Price: $4.98 BPAX Score: 1.17

Unlike most bio firms, tech research companies focused on delivery systems seem to yield larger "hits" than "misses" by applying their discoveries over broader markets; most traditional biotechs seem to have too narrow a focus, leading to significant company impact when trials fail.

Report this Post Replies: 0 | Reply

Featured Broker Partners